Ceftazidime has PSEUDOMONAS coverage; HENS PECK MA (h. influenza, e. coli, n. meningitides, salmonella, serratia, proteus, enterobacter, citrobacter, klebsiella, m. catarrhalis, acinetobacter)
HENS PECK MA (h. influenza, e. coli, n. meningitides, salmonella, serratia, proteus, enterobacter, citrobacter, klebsiella, m. catarrhalis, acinetobacter)
PO drug of choice when switching from IV cephalosporin
OTOTOXICITY, neprhotoxicity, Red Man's syndrome (1g/hr max)
blocks glycosidic bond (PBP; transglycosidase) and peptide bond (transpeptidase); causes weak cell wall and bacterial lysis; IV (po given only for colitis), DOSE DEPENDENT on total body weight, dose adjust, Narrow therapeutic index (monitor troughs)
Daptomycin
b-lactam; cyclic lipopetide
MRSA G+ (strep, staph aureus), enterococcus faecalis and faecium, including VRE
Complicated skin and skin structure infx (cSSSI), surgical sites, traumatic wounds, ulcers, abscesses, cellulitis...NEVER for PNEUMONIA
Muscle pain and weakness, CPK elevations (monitor weekly)
IV only, renal excretion, dose adjust; binds and depolarizes cell causing efflux of K+ and cell death; low risk of cross-resistance with other b-lactams b/c of unique mechanism
G+ (staph non-MRSA, strep/s. pneumoniae, E. faecalis), G-s (Levofloxacin for PSEUDOMONAS); some anaerobes (not C. dificile), "atypicals"
Pneumonia; respiratory "above the waist" infx; ok for UTIs, STDs
must separate from food w/complex metallic ions; hypo/hyperglycemia, CNS, QT prolongation, tendon rupture; Gemifloxacin - rash
IV, PO (gemifloxacin only PO); inhibit topoisomerase (DNA gyrase) preventing supercoiling of DNA; resistance by target site modification and efflux pump; Mefloxacin hepatically metabolized; the rest need renal adjustment
Ciprofloxacin
2nd gen. Fluoroquinolones
1st choice FQ for PSEUDOMONAS; G-s, "atypicals"
Anthrax; "below the waist" UTIs, STDs (gonnorrhea); poor S. pneumonia coverage
metabolized by CYP-1A2; must separate from food w/complex metallic ions; hypo/hyperglycemia, CNS, QT prolongation, tendon rupture
inhibit topoisomerase (DNA gyrase) preventing supercoiling of DNA; resistance by target site modification and efflux pump
Drug of choice for: stenotropomonas multiphilia nocardia sp.; some lesser G-s (e. coli, klebsiella
(resistance: altered target site AND overproduction of PABA)
First line for: acute cystitis (bladder UTI), traveler's diarrhea, Pneumocystis jiroveci
rarely used as a single agent b/c of synergistic effects (except TMP in UTIs)
highly bound ptn displaces unconjugated bilirubin from albumin causes kernicterus
allergies, rash can be fatal if SJS, GI symptoms, myelosuppression, hyperkalemia
step 1: PABA converted by folic acid sythetase to dihydroflic acid (sulfonamides mimic PABA and compete for enzyme)
step 2: dihydrofolate acid converted to tetrahydrofolic acid by DHA reductase
step 3: tetrahydrofolate helps produce nucleotide
PO, (IV); competitive antagonism; inhibits mycolic acid synthesis for cell wall; no renal adj.. avoid liver pts
Rifampin
(blank)
G+s
safe in pregnancy
CYP450 induction...MOST DRUG INTERACTION OF ALL TB agents; hepatotoxicity, discoloration of body fluids!
inhibits DNA-dependent RNA polymerases
Pyrazinimide
(blank)
(blank)
(blank)
hepatotoxicity, ARTHRALGIAS, Gouty arthritis; contraindicated in gout
PO only; dependent on presence of pyrazinamidase; renal excretion mostly, adj dose
Ethambutol
(blank)
(blank)
best with rapidly dividing M. tuberculosis
retrobulbar neuritis (visual disturbance with colors: red/green); NO HEPATOTOXICITY
PO only; renal excretion, adj dose
Fluoroquinolones/Aminoglycosides
ptn synthesis inhibitors
(blank)
1. moxifloxacin, levofloxacin gatifloxacin --> resistant to all or none; 2. amikacin/kanamyxin (cross resistance 100%, less vestibular dysf than streptomycin); 3. streptomycin (works w/ strains resistant to amikacin/kanamycin with less nephrotoxicity)
celll wall; inhibits alanine racemase preventing peptide bond
Ethionamide
second line drugs for Active TB
resistant strains
(blank)
GI, hepatotoxicity, NEUROTOXICITY (peripheral and optic)!!
(blank)
P-aminosalicylic acid (PAS)
(blank)
(blank)
avoid in pregnancy if possible
Hypothyroidism, GI, hepatotoxicity
similar to sulfonamides; competes with PABA; no renal adj
Chloroquine
antiparasitic
malaria (P. falciparum tx); active against sensitive malarial infections in blood stage
Prophylaxis/Tx of Malaria
Screen for G6PD; pruritis, GI
somehow prevents conversion from heme to hemozoin (buildup kills parasite); PO rapidly absorbed with large vol distribution; 1/2-life 1-2 months; urine excretion; DOES NOT work on hepatic stage
Primaquine
antiparasitic
Malaria (P. vivax and P. ovale) in hepatic stage
Mararia prophylaxis/Tx
Check G6PD - hemolysis; GI; leukopenia
PO rapidly absorbed large vol distribution; urine excretion; DOES NOT work on blood stage
Mefloquine
antiparasitic
Mararia (P. falciparum and P. vivax); choroquine resistant strains; blood stage
Prophylaxis for chloroquine resistant malaria
Neuropsychiatric toxicity; myelosuppression; GI
PO good absorption large vol of distribution; terminal 1/2-life is 20days allowing weekly dosing
Quinine/Quinidine
antiparasitic
Malaria (P. faliparum) blood stage
Tx only choice for severe P. falciparin (after chloroquine)...no prophylaxis because of adverse effects
Quinine: PO only; Quinidine: IV only; not active against hepatic stage
Doxycycline/Clindamycin
antibiotics
malaria
Doxycyclin: prophylactic drug of choice in SE Asia for blood stage; usually combined with quinine/quinidine; Clindamycin is safe for children/pregnant/breastfeeding mothers
(blank)
not active against hepatic stage
Atovaquone-Proguanil (Malarone)
antifolate agent
Malaria (P. falciparum only)
Prophylaxis only
(blank)
inhibits bacterial DNA synthesis; expensive; shorter pre/post exposure Tx
Sulfadoxine
antifolate
malaria (P. falciparum only)
Standard cost-effective single dose Tx in Africa
(blank)
(blank)
Iodoquinolol
(blank)
trophozoites in bowel lumen
Amebiasis therapy - luminal agent
contraindicated for pts with iodine allergy; diarrhea
PO only; 10% absorbed so it is not active in intestinal wall or extraintestinal tissue; excreted in feces
Paromomycin
aminoglycoside antibiotic
trophozoites in bowel lumen
amebiasis therapy - luminal agent
Caution with renal insufficiency (avoid if serious); diarrhea, GI
PO only; little absorption; 7-day therapy; better tolerated than iodoquinol
Metronidazole (Flagyl)
nitroimidazole
C. dificile-associated diarrhea; anaerobics; amebiasis; giardiasis; trichomoniasis; bacterial vaginosis
amebiasis therapy - tissue agent; anaerobes; parasites; active against intestinal wall and extraintestinal infections
alcohol intolerance; peripheral neuoropathy; metallic taste; GI
PO 100% bioavailable; high penetration to most sites; hepatic metabolism/renal elimination
Tindazole (Tindamax)
(blank)
Giardiasis; trichomoniasis
amebiasis therapy - tissue agent
(blank)
(blank)
Stibogluconate sodium (pentavalent antimony)
(blank)
Leishmaniasis
First-line for all leishmaniasis infx (except in certain parts of India)
GI; myalgias/arthralgias; QT prolongation
IV, (IM)
Pentamidine
(blank)
Leishmaniasis; African sleeping sickness
Leishmaniasis; African sleepin sickness; last-line for PCP pneumonia
Very Toxic; pancreatitis; renal damage; bronchospasm (inhaled)
IV or inhaled; alternative to Stibogluconate Sodium
Albendazole, Mebendazole, Thiabendazole
Helminth agents
worms (primarily nematodes)
nematodes
short term: GI; long term: increased LFTs, pancytopenia; Thiabendazole rarely used d/t toxicity
PO only; fatty meals increase absorption; inhibits microtubule synthesis in parasites
Praziquantel
Helminth agent
Flukes, tapeworms
primarily tremadotes and cestodes
headache, dizziness, fatigue
PO only (swallow tablets whole); excreted renally; increases parasitic cell membrane permeability to Ca